Search clinical trials for: RO5313534

Total 2 results

Hoffmann-La Roche

Completed

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Germany, Mexico, Poland, Spain, United States, France, Canada, Italy, Slovakia, Argentina, Australia, United Kingdom, Romania
Hoffmann-La Roche

Completed

A Study of the Effect of Memantine on Pharmacokinetics, Safety and Tolerability of Single Dose RO5313534 in Healthy Volunteers, and the Effect of RO5313534 on Safety and Tolerability of Steady State Memantine

Healthy Volunteer

France

3

Subscribe